Skip to main content
Equibles

GUGGENHEIM CAPITAL LLC

Position in INSM — INSMED Inc

CIK 1283072 Chicago, IL
Back to INSM Full portfolio

Position in INSM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,133,230
-$8,951,803 QoQ
Shares Held
38,766
-51.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#228
of 666 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in INSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GUGGENHEIM CAPITAL LLC holds $211,944,812 across 76 Biotechnology names. INSM ranks #6 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 115,233 $57,239,687
2 REGN
Regeneron Pharmaceuticals, Inc.
 45,969 $28,663,508
3 ALNY
Alnylam Pharmaceuticals, Inc.
 39,318 $11,835,897
4 INCY
Incyte Corp
 57,780 $6,549,940
5 RVMD
Revolution Medicines, Inc.
 26,474 $4,958,050
6 INSM
INSMED Inc
This page 		38,766 $4,133,230
7 MRNA
Moderna, Inc.
 55,313 $3,873,568
8 BMRN
Biomarin Pharmaceutical Inc
 66,874 $3,826,530

All Filings in INSM

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,133,230 38,766
2026-03-31 $13,085,033 80,021
2025-12-31 $14,321,925 82,291
2025-09-30 $5,308,207 36,860
2025-06-30 $4,165,590 41,391
2025-03-31 $2,704,175 35,446
2024-12-31 $2,370,971 34,342
2024-09-30 $2,723,265 37,305
2024-06-30 $2,445,500 36,500
2024-03-31 $1,375,273 50,692
2023-12-31 $1,363,869 44,010
2023-09-30 $1,310,928 51,918
2023-06-30 $1,278,215 60,579
2023-03-31 $1,071,369 62,837